tetano
Editor, Senior Moderator
Sens Actuators B Chem
. 2021 Oct 15;345:130394.
doi: 10.1016/j.snb.2021.130394. Epub 2021 Jul 3.
Developing an Optical Interferometric Detection Method based biosensor for detecting specific SARS-CoV-2 immunoglobulins in Serum and Saliva, and their corresponding ELISA correlation
A M M Murillo[SUP] 1 2 [/SUP], J Tomé-Amat[SUP] 3 [/SUP], Y Ramírez[SUP] 1 2 [/SUP], M Garrido-Arandia[SUP] 3 [/SUP], L G Valle[SUP] 1 4 [/SUP], G Hernández-Ramírez[SUP] 3 [/SUP], L Tramarin[SUP] 1 4 5 [/SUP], P Herreros[SUP] 1 4 5 [/SUP], B Santamaría[SUP] 1 4 [/SUP], A Díaz-Perales[SUP] 3 4 [/SUP], M Holgado[SUP] 1 4 5 [/SUP]
Affiliations
Abstract
The standard rapid approach for the diagnosis of coronavirus disease 2019 (COVID-19) is the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA. The detection of specific anti-SARS-CoV-2 immunoglobulins is crucial for screening people who have been exposed to the virus, whether or not they presented symptoms. Recent publications report different methods for the detection of specific IgGs, IgMs, and IgAs against SARS-CoV-2; these methods mainly detect immunoglobulins in the serum using conventional techniques such as rapid lateral flow tests or enzyme-linked immunosorbent assay (ELISA). In this article, we report the production of recombinant SARS-CoV-2 spike protein and the development of a rapid, reliable, cost-effective test, capable of detecting immunoglobulins in serum and saliva samples. This method is based on interferometric optical detection. The results obtained using this method and those obtained using ELISA were compared. Owing to its low cost and simplicity, this test can be used periodically for the early detection, surveillance, detection of immunity, and control of the spread of COVID-19.
Keywords: Biosensing; Immunoglobulins; Interferometric optical detection method; SARS-CoV-2; Saliva; Serum.
. 2021 Oct 15;345:130394.
doi: 10.1016/j.snb.2021.130394. Epub 2021 Jul 3.
Developing an Optical Interferometric Detection Method based biosensor for detecting specific SARS-CoV-2 immunoglobulins in Serum and Saliva, and their corresponding ELISA correlation
A M M Murillo[SUP] 1 2 [/SUP], J Tomé-Amat[SUP] 3 [/SUP], Y Ramírez[SUP] 1 2 [/SUP], M Garrido-Arandia[SUP] 3 [/SUP], L G Valle[SUP] 1 4 [/SUP], G Hernández-Ramírez[SUP] 3 [/SUP], L Tramarin[SUP] 1 4 5 [/SUP], P Herreros[SUP] 1 4 5 [/SUP], B Santamaría[SUP] 1 4 [/SUP], A Díaz-Perales[SUP] 3 4 [/SUP], M Holgado[SUP] 1 4 5 [/SUP]
Affiliations
- PMID: 34248283
- PMCID: PMC8253720
- DOI: 10.1016/j.snb.2021.130394
Abstract
The standard rapid approach for the diagnosis of coronavirus disease 2019 (COVID-19) is the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA. The detection of specific anti-SARS-CoV-2 immunoglobulins is crucial for screening people who have been exposed to the virus, whether or not they presented symptoms. Recent publications report different methods for the detection of specific IgGs, IgMs, and IgAs against SARS-CoV-2; these methods mainly detect immunoglobulins in the serum using conventional techniques such as rapid lateral flow tests or enzyme-linked immunosorbent assay (ELISA). In this article, we report the production of recombinant SARS-CoV-2 spike protein and the development of a rapid, reliable, cost-effective test, capable of detecting immunoglobulins in serum and saliva samples. This method is based on interferometric optical detection. The results obtained using this method and those obtained using ELISA were compared. Owing to its low cost and simplicity, this test can be used periodically for the early detection, surveillance, detection of immunity, and control of the spread of COVID-19.
Keywords: Biosensing; Immunoglobulins; Interferometric optical detection method; SARS-CoV-2; Saliva; Serum.